Reviewed
Verified by SAC team
+20
XP on completion
Trusted Alpha-GPC
NOW Foods

NOW Alpha GPC 300mg Review

NOW's Alpha-GPC is a reputable, GMP-made version of the most brain-bioavailable choline form. Alpha-GPC crosses the blood-brain barrier and is favored for cognition and athletic focus. On a liver list, though, it is the poorest fit: it delivers only ~120mg elemental choline per 300mg cap and has no meaningful NAFLD evidence, so it lands near the bottom despite NOW being a trusted brand.

Check on Amazon

Affiliate link — Super Achiever Club earns a small commission at no extra cost to you.

Read the complete Choline guide →
▸ THE SCORE

How we built the SAC Product Score™5.8/10

Form & bioavailability (liver/methylation fit)30%5/10

Alpha-GPC is superbly bioavailable to the brain but that is not the liver's need. It is the least relevant common form for hepatic fat handling.

Dose vs RDA/clinical range20%5.5/10

300mg Alpha-GPC yields only ~120mg elemental choline (~40%), well below the RDA and low for a liver top-up.

Third-party testing & purity20%6/10

NOW is GMP-certified, Non-GMO and vegetarian with a respected quality reputation, though not clinician-line documentation.

Tolerability & safety15%7.5/10

Alpha-GPC is well tolerated; headache or GI effects are uncommon at this dose. A cardiovascular signal reported in one observational analysis warrants moderation, not alarm.

Value15%6/10

Around $18 for 60 caps is reasonable for Alpha-GPC but expensive per gram of elemental choline versus bitartrate.

▸ SPECS

The product at a glance

Form
Veg capsule (Alpha-GPC)
Dose
300mg Alpha-GPC (~120mg elemental choline) per capsule
Count
60 capsules
Standardization
~40% choline by weight
Testing
Non-GMO, vegetarian, GMP
Cost per dose
~$0.30 per capsule (approx, not live-checked)
▸ TRUTH CHECK

Marketing claims vs. reality

Verified

Alpha-GPC is highly bioavailable and supports cognition

Alpha-GPC crosses the blood-brain barrier and improved cognition in a controlled dementia trial (PMID 12637119), supporting its brain positioning.

Not verified

Suitable for fatty liver support

There is no meaningful NAFLD evidence for Alpha-GPC, and at ~120mg elemental choline per cap it is a weak choline top-up (PMID 22337211).

▸ THE DEEP DIVE

What our test actually found

01Best brain form, poorest liver fit

Alpha-GPC's blood-brain-barrier penetration is its virtue for cognition (PMID 12637119) but irrelevant to hepatic fat export, which is why it ranks near the bottom of a liver list.

02Low elemental choline per capsule

At ~40% choline by weight, 300mg Alpha-GPC delivers only ~120mg elemental choline, so it is an inefficient way to reach choline adequacy for the liver.

▸ THE TRADE-OFFS

Pros & cons, no sugar-coating

Pros
  • Most brain-bioavailable choline form
  • Trusted GMP, Non-GMO, vegetarian brand
  • Well tolerated at 300mg
  • Good option if cognition is the real goal
Cons
  • Off-target for liver health
  • Only ~120mg elemental choline per cap
  • Expensive per gram of choline; an observational cardiovascular signal warrants moderation
▸ THE BOTTOM LINE

A brain supplement in the wrong aisle

NOW Alpha-GPC is a fine cognition choice, but for the liver/methylation goal it is the weakest common form. If liver is your aim, choose the Pure Encapsulations bitartrate or Thorne phosphatidylcholine instead.

Check NOW Foods on Amazon
▸ ALTERNATIVES

If this doesn’t fit — try these

▸ RESEARCH

Sources & further reading

  1. De Jesus Moreno Moreno M. Clin Ther. 2003;25(1):178-193.De Jesus Moreno Moreno M · 2003 · Clinical Therapeutics · PMID 12637119

    Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial

    Alpha-GPC (choline alfoscerate) improved cognitive scores versus placebo, establishing its cognitive, not hepatic, evidence base.

  2. Corbin KD, Zeisel SH. Curr Opin Gastroenterol. 2012;28(2):159-165.Corbin KD, Zeisel SH · 2012 · Current Opinion in Gastroenterology · PMID 22134222

    Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression

    No choline form, including Alpha-GPC, is an established NAFLD therapy; benefit is confined to correcting deficiency.